354 related articles for article (PubMed ID: 26852243)
21. Helical tomotherapy for head and neck squamous cell carcinoma: dosimetric comparison with linear accelerator-based step-and-shoot IMRT.
Murthy V; Master Z; Gupta T; Ghosh-Laskar S; Budrukkar A; Phurailatpam R; Agarwal J
J Cancer Res Ther; 2010; 6(2):194-8. PubMed ID: 20622367
[TBL] [Abstract][Full Text] [Related]
22. Multi-scenario based robust intensity-modulated proton therapy (IMPT) plans can account for set-up errors more effectively in terms of normal tissue sparing than planning target volume (PTV) based intensity-modulated photon plans in the head and neck region.
Stuschke M; Kaiser A; Abu Jawad J; Pöttgen C; Levegrün S; Farr J
Radiat Oncol; 2013 Jun; 8():145. PubMed ID: 23773560
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.
Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169
[TBL] [Abstract][Full Text] [Related]
24. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
[TBL] [Abstract][Full Text] [Related]
25. Helical tomotherapy for the treatment of anal canal cancer: a dosimetric comparison with 3D conformal radiotherapy.
Ugurluer G; Ballerini G; Moeckli R; Matzinger O; Bourhis J; Ozsahin M
Tumori; 2015; 101(3):268-72. PubMed ID: 25908035
[TBL] [Abstract][Full Text] [Related]
26. Re-irradiation of recurrent head and neck carcinomas: comparison of robust intensity modulated proton therapy treatment plans with helical tomotherapy.
Stuschke M; Kaiser A; Abu-Jawad J; Pöttgen C; Levegrün S; Farr J
Radiat Oncol; 2013 Apr; 8():93. PubMed ID: 23601204
[TBL] [Abstract][Full Text] [Related]
27. [Constraints of the dentist are consistent with the results of an optimal irradiation with modulated intensity in N0 oropharyngeal cancer].
Jaussaud S; Guihard S; Niederst C; Borel C; Meyer P; Hémar P; Schultz P; Noël G; Féki A
Cancer Radiother; 2013; 17(4):265-71. PubMed ID: 23726044
[TBL] [Abstract][Full Text] [Related]
28. Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy.
Chi A; Lin LC; Wen S; Yan H; Hsi WC
Radiat Oncol; 2017 Aug; 12(1):132. PubMed ID: 28810881
[TBL] [Abstract][Full Text] [Related]
29. Can We Spare the Pancreas and Other Abdominal Organs at Risk? A Comparison of Conformal Radiotherapy, Helical Tomotherapy and Proton Beam Therapy in Pediatric Irradiation.
Jouglar E; Wagner A; Delpon G; Campion L; Meingan P; Bernier V; Demoor-Goldschmidt C; Mahé MA; Lacornerie T; Supiot S
PLoS One; 2016; 11(10):e0164643. PubMed ID: 27764132
[TBL] [Abstract][Full Text] [Related]
30. SmartArc-based volumetric modulated arc therapy for oropharyngeal cancer: a dosimetric comparison with both intensity-modulated radiation therapy and helical tomotherapy.
Clemente S; Wu B; Sanguineti G; Fusco V; Ricchetti F; Wong J; McNutt T
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1248-55. PubMed ID: 20947268
[TBL] [Abstract][Full Text] [Related]
31. Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study.
Liu G; Li X; Qin A; Zheng W; Yan D; Zhang S; Stevens C; Kabolizadeh P; Ding X
Radiat Oncol; 2020 Jan; 15(1):21. PubMed ID: 32000817
[TBL] [Abstract][Full Text] [Related]
32. Extended-field bone marrow sparing radiotherapy for primary chemoradiotherapy in cervical cancer patients with para-aortic lymphadenopathy: Volumetric-modulated arc therapy versus helical tomotherapy.
Chen JL; Wang MC; Huang YS; Huang CY; Pan CK; Hsu CY; Lan KH; Kuo SH
J Xray Sci Technol; 2020; 28(1):111-124. PubMed ID: 31904003
[TBL] [Abstract][Full Text] [Related]
33. Organ sparing potential and inter-fraction robustness of adaptive intensity modulated proton therapy for lung cancer.
van der Laan HP; Anakotta RM; Korevaar EW; Dieters M; Ubbels JF; Wijsman R; Sijtsema NM; Both S; Langendijk JA; Muijs CT; Knopf AC
Acta Oncol; 2019 Dec; 58(12):1775-1782. PubMed ID: 31556764
[No Abstract] [Full Text] [Related]
34. Intensity-modulated radiotherapy or volumetric-modulated arc therapy in patients with head and neck cancer: Focus on salivary glands dosimetry.
Vallard A; Guy JB; Mengue Ndong S; Vial N; Rivoirard R; Auberdiac P; Méry B; Langrand-Escure J; Espenel S; Moncharmont C; Ben Mrad M; Diao P; Goyet D; Magné N
Head Neck; 2016 Jul; 38(7):1028-34. PubMed ID: 26855006
[TBL] [Abstract][Full Text] [Related]
35. Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer.
Ekici K; Pepele EK; Yaprak B; Temelli O; Eraslan AF; Kucuk N; Altınok AY; Sut PA; Alpak OD; Colak C; Mayadagli A
Med Dosim; 2016 Winter; 41(4):329-333. PubMed ID: 27765542
[TBL] [Abstract][Full Text] [Related]
36. Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial.
Eekers DBP; Roelofs E; Jelen U; Kirk M; Granzier M; Ammazzalorso F; Ahn PH; Janssens GORJ; Hoebers FJP; Friedmann T; Solberg T; Walsh S; Troost EGC; Kaanders JHAM; Lambin P
Radiother Oncol; 2016 Dec; 121(3):387-394. PubMed ID: 27639891
[TBL] [Abstract][Full Text] [Related]
37. Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma.
Madani I; Lomax AJ; Albertini F; Trnková P; Weber DC
Radiat Oncol; 2015 Mar; 10():72. PubMed ID: 25890217
[TBL] [Abstract][Full Text] [Related]
38. Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison.
Schwarz M; Pierelli A; Fiorino C; Fellin F; Cattaneo GM; Cozzarini C; Di Muzio N; Calandrino R; Widesott L
Radiother Oncol; 2011 Jan; 98(1):74-80. PubMed ID: 21176983
[TBL] [Abstract][Full Text] [Related]
39. Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer.
Stefanowicz S; Stützer K; Zschaeck S; Jakobi A; Troost EGC
Radiat Oncol; 2018 Nov; 13(1):228. PubMed ID: 30466468
[TBL] [Abstract][Full Text] [Related]
40. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.
Cvek J; Kubes J; Skacelikova E; Otahal B; Kominek P; Halamka M; Feltl D
Strahlenther Onkol; 2012 Aug; 188(8):666-70. PubMed ID: 22648405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
